Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Diet and Nutrition Essential for Mental Health

January 28, 2015 9:18 am | by University of Melbourne | News | Comments

Evidence is rapidly growing showing vital relationships between both diet quality and potential nutritional deficiencies and mental health. Read more....                  


Scientists Find Potential Anti-Cancer Use for Anti-Epilepsy Drug

January 28, 2015 9:11 am | by University of York | News | Comments

Scientists studied phenytoin, a drug which inhibits epilepsy by targeting sodium channels. Read more...                          


Amgen Submits Application in U.S. and Europe for Multiple Myeloma Treatment

January 28, 2015 9:05 am | News | Comments

The drug is an injection that can treat patients with relapsed multiple myeloma who have received at least one prior therapy. Read more...                     


Malvern's New Platform Enhances Analysis of Macromolecules

January 28, 2015 8:57 am | News | Comments

The platform breaks new ground in delivering the high performance, ease of use and productivity demanded in today’s analytical laboratories. Read more...            c       


Liberia: Only 5 People Being Treated for Ebola in Country

January 28, 2015 8:53 am | by Jonathan Paye-Layleh - Associated Press | News | Comments

Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country - a dramatic turnaround in the West African nation where the virus has taken its deadliest toll. Read more...        


Donors Pledge Record $7.5B for Global Vaccines Program

January 28, 2015 8:40 am | by Associated Press | News | Comments

Governments and private donors have pledged a record $7.5 billion to replenish a global vaccination program for the poor. Read more...                     


Mylan Expands Hepatitis C Licensing Agreement with Gilead

January 26, 2015 11:18 am | by Associated Press | News | Comments

 Mylan Inc. announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir(Sovaldi)/GS-5816, once approved, in 91 developing countries. Read more...


New Model for Combatting the Ebola Epidemic

January 26, 2015 11:15 am | by Columbia University | News | Comments

An ICAP team conducted a three-week rapid assessment of Ebola community care centers. Read more...                           


UK Nurse Who Contracted Ebola Recovers, Leaves Hospital

January 26, 2015 11:08 am | by Associated Press | News | Comments

A British nurse who contracted Ebola while working in Sierra Leone has been discharged from the hospital after making a complete recovery. Read more...                               


Avian Flu Confirmed in Commercial Turkey Flock in California

January 26, 2015 11:07 am | by Associated Press | News | Comments

Federal agriculture officials say they have found avian influenza in a commercial turkey flock in central California. Read more...                      


Neural Spines Operate Like Miniature Neurons

January 26, 2015 11:04 am | by LMU | News | Comments

A recent study by teams of neurobiologists based at LMU and Regensburg addresses the role of the short protrusions called “spines” that form on the dendrites of nerve cells in the mammalian olfactory bulb. Dendrites serve as receptors for signals delivered by the so-called axons of other neurons. Read more...


Shire's Hunter Syndrome Treatment Gains FDA Fast Track Designation

January 26, 2015 10:59 am | News | Comments

Shire's drug treats the neurocognitive decline associated with Hunter syndrome. Read more...                           


GSK Expands Portfolio of Asthma/COPD Medicines in U.S.

January 26, 2015 10:55 am | by GSK | News | Comments

GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the U.S. Read more...                             


Study Finds Potential New Drug Target for Lung Cancer

January 26, 2015 10:46 am | by Kentucky University | News | Comments

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer. Read more...              


How Cancer Turns Good Cells to the Dark Side

January 26, 2015 10:39 am | by Rice University | News | Comments

Cancer uses a little-understood element of cell signaling to hijack the communication process and spread, according to Rice University researchers. Read more...                             



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.